NCT04135365View on ClinicalTrials.gov

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

neurocognitive assessment

Observational study therefore there are no interventions

BEHAVIORAL

neuroimaging assessment

Observational study therefore there are no interventions

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT04135365 - Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study | Biotech Hunter | Biotech Hunter